Ole Kirk
- Virology top 0.05%
- HIV Research and Treatment 56
- Emergency Medicine top 0.01%
- HIV-related health complications and treatments 86
- Infectious Diseases top 0.05%
- HIV/AIDS drug development and treatment 107
- HIV/AIDS Research and Interventions 96
- Tuberculosis Research and Epidemiology 12
- Hepatology top 0.5%
- Hepatitis C virus research 19
- Epidemiology top 0.2%
- Pneumocystis jirovecii pneumonia detection and treatment 30
-
- Enzyme Catalysis and Immobilization 17
- Co-authors
- Jens LundgrenAmanda MocroftPeter ReissAntonella d’Arminio MonforteAndrew PhillipsCaroline SabinClaus C. FuglsangTorben V. Borchert
- Partner nations
- DenmarkUnited KingdomSwitzerland
In The Last Decade
Ole Kirk
224 papers receiving 16.2k citations
Hit Papers
Peers
Comparison fields: 5 of 173
- Virology 5.0k
- Emergency Medicine 6.6k
- Infectious Diseases 9.2k
- Hepatology 1.5k
- Epidemiology 4.6k
Countries citing papers authored by Ole Kirk
This map shows the geographic impact of Ole Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Kirk more than expected).
Fields of papers citing papers by Ole Kirk
This network shows the impact of papers produced by Ole Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Kirk. The network helps show where Ole Kirk may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ole Kirk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 31 | |
| 3 | 2021 | 10 | |
| 4 | 2021 | 4 | |
| 5 | 2019 | 9 | |
| 6 | 2019 | 17 | |
| 7 | [The current global tuberculosis state]. | 2017 | 1 |
| 8 | 2013 | 58 | |
| 9 | 2012 | 35 | |
| 10 | 2011 | 111 | |
| 11 | 2010 | 283 | |
| 12 | 2005 | 27 | |
| 13 | Changing incidence of CNS HIV-related diseases in the EuroSIDA cohort | 2004 | 2 |
| 14 | 2004 | 25 | |
| 15 | 2004 | 102 | |
| 16 | 2004 | 30 | |
| 17 | Safety of non-nucleoside reverse transcriptase therapy: data from the EuroSIDA study | 2003 | 1 |
| 18 | 2000 | 100 | |
| 19 | Stimulation of insulin release by D-glucose pentaacetate | 1997 | 1 |
| 20 | 1996 | 3 |
About Ole Kirk
Ole Kirk is a scholar working on Virology, Emergency Medicine, Infectious Diseases, Hepatology and Epidemiology, having authored 228 papers that have together received 16.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (107 papers), HIV/AIDS Research and Interventions (96 papers), HIV-related health complications and treatments (86 papers), HIV Research and Treatment (56 papers), Pneumocystis jirovecii pneumonia detection and treatment (30 papers), Hepatitis C virus research (19 papers), Enzyme Catalysis and Immobilization (17 papers) and Tuberculosis Research and Epidemiology (12 papers). The work is most often cited by research in Virology (5.0k citations), Emergency Medicine (6.6k citations), Infectious Diseases (9.2k citations), Hepatology (1.5k citations) and Epidemiology (4.6k citations). Ole Kirk has collaborated with scholars based in Denmark, United Kingdom and Switzerland. Frequent co-authors include Jens Lundgren, Amanda Mocroft, Peter Reiss, Antonella d’Arminio Monforte, Andrew Phillips, Caroline Sabin, Claus C. Fuglsang, Torben V. Borchert, Bruno Ledergerber and Nina Friis‐Møller. Their work appears in journals such as AIDS, HIV Medicine, The Journal of Infectious Diseases, Journal of the International AIDS Society and Antiviral Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.